{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T01:28:14Z","timestamp":1786584494816,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004920","name":"Royan Institute","doi-asserted-by":"crossref","award":["95000295"],"award-info":[{"award-number":["95000295"]}],"id":[{"id":"10.13039\/501100004920","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53048-8","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:07:24Z","timestamp":1780434444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor suppressor effects of miR-143 and miR-199 on the K562 myelogenous leukemia cell line by targeting the RNA-binding protein Musashi2"],"prefix":"10.1038","volume":"16","author":[{"given":"Liana","family":"Lachinani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Iranpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Forouzanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Nasr-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianoush","family":"Dormiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"3","key":"53048_CR1","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1172\/JCI78440","volume":"125","author":"S-M Park","year":"2015","unstructured":"Park, S-M. et al. Musashi2 sustains the mixed-lineage leukemia\u2013driven stem cell regulatory program. J. Clin. Invest. 125 (3), 1286\u20131298 (2015).","journal-title":"J. Clin. Invest."},{"key":"53048_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00277-012-1637-5","volume":"92","author":"F Thol","year":"2013","unstructured":"Thol, F. et al. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia. Ann. Hematol. 92, 315\u2013323 (2013).","journal-title":"Ann. Hematol."},{"issue":"1","key":"53048_CR3","first-page":"178525","volume":"2012","author":"L Wurth","year":"2012","unstructured":"Wurth, L. Versatility of RNA-binding proteins in cancer. Int. J. Genomics. 2012 (1), 178525 (2012).","journal-title":"Int. J. Genomics"},{"issue":"6","key":"53048_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4161\/rna.24641","volume":"10","author":"SA Ciafr\u00e8","year":"2013","unstructured":"Ciafr\u00e8, S. A. & Galardi, S. microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer. RNA Biol. 10 (6), 934\u2013942 (2013).","journal-title":"RNA Biol."},{"issue":"10","key":"53048_CR5","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.3390\/ijms21103409","volume":"21","author":"K Schuschel","year":"2020","unstructured":"Schuschel, K. et al. RNA-binding proteins in acute leukemias. Int. J. Mol. Sci. 21 (10), 3409 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"7307","key":"53048_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nature09171","volume":"466","author":"T Ito","year":"2010","unstructured":"Ito, T. et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature 466 (7307), 765\u2013768 (2010).","journal-title":"Nature"},{"issue":"8","key":"53048_CR7","first-page":"903","volume":"16","author":"MG Kharas","year":"2010","unstructured":"Kharas, M. G. et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nature 16 (8), 903\u2013908 (2010).","journal-title":"Nature"},{"key":"53048_CR8","doi-asserted-by":"publisher","first-page":"e03915","DOI":"10.7554\/eLife.03915","volume":"3","author":"Y Katz","year":"2014","unstructured":"Katz, Y. et al. Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state. Elife 3, e03915 (2014).","journal-title":"Elife"},{"issue":"8","key":"53048_CR9","doi-asserted-by":"publisher","first-page":"e0136484","DOI":"10.1371\/journal.pone.0136484","volume":"10","author":"Y Han","year":"2015","unstructured":"Han, Y. et al. Musashi-2 silencing exerts potent activity against acute myeloid leukemia and enhances chemosensitivity to daunorubicin. PloS one. 10 (8), e0136484 (2015).","journal-title":"PloS one"},{"key":"53048_CR10","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.2147\/CMAR.S265545","volume":"12","author":"R Wang","year":"2020","unstructured":"Wang, R., Liu, L., Jiao, J. & Gao, D. J. C. M. Research. Knockdown of MIR4435-2HG suppresses the proliferation, migration and invasion of cervical cancer cells via regulating the miR-128-3p\/MSI2 axis in vitro. Cancer Manag Res. 12, 8745 (2020).","journal-title":"Cancer Manag Res."},{"issue":"12","key":"53048_CR11","first-page":"6551","volume":"24","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. LncRNA DANCR regulates osteosarcoma migration and invasion by targeting miR-149\/MSI2 axis. Eur. Rev. Med. Pharmacol. Sci. 24 (12), 6551\u20136560 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"53048_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0921-1","volume":"37","author":"Y Zhan","year":"2018","unstructured":"Zhan, Y. et al. Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149\/MSI2 axis as a ceRNA. J. Exp. Clin. Cancer Res. 37 (1), 1\u201312 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"53048_CR13","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (7), 1401\u20131414 (2007).","journal-title":"Cell"},{"issue":"23","key":"53048_CR14","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1073\/pnas.232087499","volume":"99","author":"S Sakakibara","year":"2002","unstructured":"Sakakibara, S. et al. RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. PNAS 99 (23), 15194\u201315199 (2002).","journal-title":"PNAS"},{"issue":"13","key":"53048_CR15","doi-asserted-by":"publisher","first-page":"7156","DOI":"10.3390\/ijms22137156","volume":"22","author":"L Anelli","year":"2021","unstructured":"Anelli, L., Zagaria, A., Specchia, G., Musto, P. & Albano, F. Dysregulation of miRNA in leukemia: exploiting miRNA expression profiles as biomarkers. Int. J. Mol. Sci. 22 (13), 7156 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"53048_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.blre.2016.11.003","volume":"31","author":"Q Fernandes","year":"2017","unstructured":"Fernandes, Q. MicroRNA: defining a new niche in Leukemia. Blood Rev. 31 (3), 129\u2013138 (2017).","journal-title":"Blood Rev."},{"key":"53048_CR17","doi-asserted-by":"crossref","unstructured":"Lan, H., Lu, H., Wang, X. & Jin, H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed. Res. Int. 2015, 125094  (2015).","DOI":"10.1155\/2015\/125094"},{"issue":"7311","key":"53048_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature09284","volume":"467","author":"PP Medina","year":"2010","unstructured":"Medina, P. P., Nolde, M. & Slack, F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467 (7311), 86\u201390 (2010).","journal-title":"Nature"},{"issue":"12","key":"53048_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3166","volume":"11","author":"AL Kasinski","year":"2011","unstructured":"Kasinski, A. L. & Slack, F. J. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer. 11 (12), 849\u2013864 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"53048_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gm516","volume":"5","author":"C Stahlhut","year":"2013","unstructured":"Stahlhut, C. & Slack, F. J. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome Med. 5, 1\u201312 (2013).","journal-title":"Genome Med."},{"issue":"24","key":"53048_CR21","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin, G. A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. PNAS 99 (24), 15524\u201315529 (2002).","journal-title":"PNAS"},{"key":"53048_CR22","doi-asserted-by":"crossref","unstructured":"Cimmino, A. et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. PNAS. 102(39), 13944-9 (2005).","DOI":"10.1073\/pnas.0506654102"},{"issue":"5","key":"53048_CR23","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3892\/or.2014.3078","volume":"31","author":"J-Z Shen","year":"2014","unstructured":"Shen, J-Z., Zhang, Y-Y., Fu, H-Y., Wu, D-S. & Zhou, H-R-J-O. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells. Oncol. Rep. 31 (5), 2035\u20132042 (2014).","journal-title":"Oncol. Rep."},{"issue":"21","key":"53048_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1182\/blood.V122.21.1271.1271","volume":"122","author":"AJ Favreau","year":"2013","unstructured":"Favreau, A. J., Duarte, C. W. & Sathyanarayana, P. Mir-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications in FAB-M5 subtype. Blood 122 (21), 1271 (2013).","journal-title":"Blood"},{"key":"53048_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cbi.2018.06.006","volume":"291","author":"P-H Chen","year":"2018","unstructured":"Chen, P-H. et al. microRNA-199a\/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells. Chem. Biol. Interact. 291, 144\u2013151 (2018).","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"53048_CR26","doi-asserted-by":"publisher","first-page":"025002","DOI":"10.1088\/2057-1739\/1\/2\/025002","volume":"1","author":"J Candia","year":"2015","unstructured":"Candia, J. et al. Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach. Converg Sci. Phys. Oncol. 1 (2), 025002 (2015).","journal-title":"Converg Sci. Phys. Oncol."},{"key":"53048_CR27","doi-asserted-by":"crossref","unstructured":"Rokah, O. H. et al. Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS One 7  (4), e35501 (2012).","DOI":"10.1371\/journal.pone.0035501"},{"key":"53048_CR28","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J-W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, e05005 (2015).","journal-title":"Elife"},{"issue":"D1","key":"53048_CR29","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 48 (D1), D127\u2013D31 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"53048_CR30","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht, C., De La Torre, C., Parveen, A. & Gretz, N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One. 13 (10), e0206239 (2018).","journal-title":"PLoS One"},{"issue":"5","key":"53048_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37 (5), 495\u2013500 (2005).","journal-title":"Nat. Genet."},{"issue":"22","key":"53048_CR32","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.1093\/nar\/gks901","volume":"40","author":"CE Vejnar","year":"2012","unstructured":"Vejnar, C. E. & Zdobnov, E. M. MiRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res. 40 (22), 11673\u201311683 (2012).","journal-title":"Nucleic Acids Res."},{"issue":"suppl_1","key":"53048_CR33","doi-asserted-by":"publisher","first-page":"D135","DOI":"10.1093\/nar\/gkj135","volume":"34","author":"PW Hsu","year":"2006","unstructured":"Hsu, P. W. et al. miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes. Nucleic Acids Res. 34 (suppl_1), D135\u2013D9 (2006).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"53048_CR34","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"H-Y Huang","year":"2022","unstructured":"Huang, H-Y. et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA\u2013target interactions. Nucleic Acids Res. 50 (D1), D222\u2013D30 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"suppl_2","key":"53048_CR35","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kr\u00fcger","year":"2006","unstructured":"Kr\u00fcger, J. & Rehmsmeier, M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 34 (suppl_2), W451\u2013W4 (2006).","journal-title":"Nucleic Acids Res."},{"issue":"24","key":"53048_CR36","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1093\/bioinformatics\/bts615","volume":"28","author":"P Loher","year":"2012","unstructured":"Loher, P. & Rigoutsos, I. Interactive exploration of RNA22 microRNA target predictions. Bioinformatics 28 (24), 3322\u20133323 (2012).","journal-title":"Bioinformatics"},{"issue":"1","key":"53048_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12860-021-00348-8","volume":"22","author":"M Forouzanfar","year":"2021","unstructured":"Forouzanfar, M., Lachinani, L., Dormiani, K. & Nasr-Esfahani, M. H. Ghaedi KJBm, biology c. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b. BMC Mol. Cell. Biol. 22 (1), 1\u201312 (2021).","journal-title":"BMC Mol. Cell. Biol."},{"issue":"7","key":"53048_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/metabo12070588","volume":"12","author":"M Malakootian","year":"2022","unstructured":"Malakootian, M., Naeli, P., Mowla, S. J. & Seidah, N. G. Post-Transcriptional Effects of miRNAs on PCSK7 Expression and Function: miR-125a-5p, miR-143-3p, and miR-409-3p as Negative Regulators. Metabolites 12 (7), 588 (2022).","journal-title":"Metabolites"},{"issue":"1","key":"53048_CR39","doi-asserted-by":"publisher","first-page":"1333882","DOI":"10.1080\/20013078.2017.1333882","volume":"6","author":"DS Sutaria","year":"2017","unstructured":"Sutaria, D. S. et al. Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery. J. Extracell. Vesicles. 6 (1), 1333882 (2017).","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"53048_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2014.03.049","volume":"542","author":"D Joshi","year":"2014","unstructured":"Joshi, D., Chandrakala, S., Korgaonkar, S., Ghosh, K. & Vundinti, B. R. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34. 1 deleted BCR\/ABL positive CML patients. Gene 542 (2), 109\u2013112 (2014).","journal-title":"Gene"},{"issue":"1","key":"53048_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10739","volume":"7","author":"J Taggart","year":"2016","unstructured":"Taggart, J. et al. MSI2 is required for maintaining activated myelodysplastic syndrome stem cells. Nat. Commun. 7 (1), 1\u20138 (2016).","journal-title":"Nat. Commun."},{"issue":"5","key":"53048_CR42","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.fertnstert.2012.11.055","volume":"99","author":"M Adammek","year":"2013","unstructured":"Adammek, M. et al. MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertil. Steril. 99 (5), 1346\u20131355 (2013). e5.","journal-title":"Fertil. Steril."},{"issue":"2","key":"53048_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2011.01.001","volume":"19","author":"J Hou","year":"2011","unstructured":"Hou, J. et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a\/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell. 19 (2), 232\u2013243 (2011).","journal-title":"Cancer Cell."},{"issue":"10","key":"53048_CR44","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.7150\/ijbs.70312","volume":"18","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. miR-199a-3p\/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer. Int. J. Biol. Sci. 18 (10), 4187 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"53048_CR45","unstructured":"Xu, C., Zhu, L-X., Sun, D-M., Yao, H. & Han, D-X. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p. Eur. Rev. Med. Pharmacol. Sci. 24 (4), 1672\u20131681 (2020)."},{"key":"53048_CR46","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1007\/s13277-015-3409-z","volume":"36","author":"L Shen","year":"2015","unstructured":"Shen, L. et al. MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT\/mTOR signaling pathway. Tumour Biol. 36, 6929\u20136938 (2015).","journal-title":"Tumour Biol."},{"issue":"2","key":"53048_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2011.04.005","volume":"307","author":"S Noguchi","year":"2011","unstructured":"Noguchi, S. et al. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer lett. 307 (2), 211\u2013220 (2011).","journal-title":"Cancer lett."},{"issue":"2","key":"53048_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.gene.2012.12.031","volume":"517","author":"Y Ni","year":"2013","unstructured":"Ni, Y. et al. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene 517 (2), 197\u2013204 (2013).","journal-title":"Gene"},{"issue":"5","key":"53048_CR49","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ymthe.2019.03.004","volume":"27","author":"T Takai","year":"2019","unstructured":"Takai, T. et al. Synthetic miR-143 exhibited an anti-cancer effect via the downregulation of K-RAS networks of renal cell cancer cells in vitro and in vivo. Mol. Ther. 27 (5), 1017\u20131027 (2019).","journal-title":"Mol. Ther."},{"issue":"3","key":"53048_CR50","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1080\/21655979.2022.2044277","volume":"13","author":"C Ding","year":"2022","unstructured":"Ding, C. et al. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2. Bioengineered 13 (3), 6629\u20136640 (2022).","journal-title":"Bioengineered"},{"issue":"2","key":"53048_CR51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/blood-2010-03-277012","volume":"117","author":"DT Starczynowski","year":"2011","unstructured":"Starczynowski, D. T. et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood 117 (2), 595\u2013607 (2011).","journal-title":"Blood"},{"issue":"5","key":"53048_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/CCO.0000000000000657","volume":"32","author":"Z Han","year":"2020","unstructured":"Han, Z., Rosen, S. T. & Querfeld, C. Targeting miRNA in hematologic malignancies. Curr. Opin. Oncol. 32 (5), 535 (2020).","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"53048_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.yexcr.2013.09.009","volume":"320","author":"H Zhang","year":"2014","unstructured":"Zhang, H. et al. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway. Exp. Cell. Res. 320 (1), 119\u2013127 (2014).","journal-title":"Exp. Cell. Res."},{"key":"53048_CR54","doi-asserted-by":"crossref","unstructured":"Yang, F. et al. MicroRNAs are key molecules involved in the gene regulation network of colorectal cancer. Front. Cell. Dev. Biol. 10, 828128 (2022).","DOI":"10.3389\/fcell.2022.828128"},{"issue":"2","key":"53048_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.canlet.2012.10.017","volume":"328","author":"S Noguchi","year":"2013","unstructured":"Noguchi, S. et al. Replacement treatment with microRNA-143 and-145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K\/Akt and MAPK signaling pathways. Cancer Lett. 328 (2), 353\u2013361 (2013).","journal-title":"Cancer Lett."},{"issue":"7","key":"53048_CR56","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/cas.14035","volume":"110","author":"T Tsujino","year":"2019","unstructured":"Tsujino, T. et al. MicroRNA-143\/Musashi\u20102\/KRAS cascade contributes positively to carcinogenesis in human bladder cancer. Cancer Sci. 110 (7), 2189\u20132199 (2019).","journal-title":"Cancer Sci."},{"issue":"23","key":"53048_CR57","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1016\/j.febslet.2014.09.047","volume":"588","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. FEBS Lett. 588 (23), 4504\u20134512 (2014).","journal-title":"FEBS Lett."},{"issue":"13","key":"53048_CR58","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.18632\/oncotarget.3604","volume":"6","author":"Y Kinose","year":"2015","unstructured":"Kinose, Y. et al. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. Oncotarget 6 (13), 11342 (2015).","journal-title":"Oncotarget"},{"issue":"1","key":"53048_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-13-220","volume":"13","author":"X Yan","year":"2014","unstructured":"Yan, X. et al. miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer. Mol. Cancer. 13 (1), 1\u201314 (2014).","journal-title":"Mol. Cancer"},{"issue":"5","key":"53048_CR60","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3892\/ijo.2016.3677","volume":"49","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Int. J. Oncol. 49 (5), 2037\u20132045 (2016).","journal-title":"Int. J. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53048-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53048-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53048-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T01:01:40Z","timestamp":1786582900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53048-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53048"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53048-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7471306\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of Royan Institute (Approval ID: IR.ACECR.ROYAN.REC.1396.103. All methods were performed in accordance with the relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25194"}}